Veterinary Diagnostics Market By Product Type (Clinical Biochemistry; Hematology; Molecular Diagnostics; Immunodiagnostics; Diagnostic Imaging; Urinalysis; Microbiology Testing); By Animal Type (Companion Animals (Dogs, Cats, Horses, Others); Livestock Animals (Cattle, Swine, Poultry, Sheep & Goats, Others)); By Technology (ELISA; PCR (Polymerase Chain Reaction); Lateral Flow Assay; Immunohistochemistry; Mass Spectrometry; Biosensors); By End User (Veterinary Hospitals & Clinics; Reference Laboratories; Point-of-Care Testing Centers; Research Institutes & Universities); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

Introduction and Veterinary Diagnostics Market Size

The Veterinary Diagnostics Market is experiencing substantial growth, driven by the rising prevalence of animal diseases, increasing pet adoption, and advancements in diagnostic technologies. In 2023, the global market was valued at approximately $8.5 billion and is projected to expand at a CAGR of 9.1% from 2024 to 2032, reaching over $18 billion by the end of the forecast period.

 

The market encompasses a wide range of diagnostic solutions, including immunodiagnostics, molecular diagnostics, clinical biochemistry, hematology & imaging systems, catering to both companion and livestock animals. The growing awareness of zoonotic diseases and their impact on human health has further fueled demand for rapid and accurate veterinary diagnostics. Additionally, advancements in point-of-care testing (POCT) & AI-powered diagnostic tools are revolutionizing the industry, allowing veterinarians to detect diseases at an early stage.

 

Leading players like Idexx Laboratories, Zoetis, Heska Corporation & Thermo Fisher Scientific are actively investing in R&D to introduce innovative and cost-effective solutions. The expansion of veterinary hospitals, increasing government initiatives for animal health & growing demand for pet insurance are expected to drive the market forward, making veterinary diagnostics a critical segment in the global healthcare industry.

 

Veterinary Diagnostics Market Dynamics

Market Drivers

Increasing Pet Ownership & Spending on Animal Healthcare: With the rising trend of pet humanization, pet owners are spending more on healthcare, including diagnostics. According to the American Pet Products Association (APPA), pet care spending in the U.S. reached $136.8 billion in 2022, with veterinary care and product sales accounting for $35.9 billion. This growing expenditure on pet healthcare fuels demand for advanced diagnostic solutions. The rise in pet insurance adoption in countries like the U.S., Canada & the U.K. has significantly contributed to increased veterinary visits and diagnostic procedures. Companies like Idexx Laboratories and Zoetis have expanded their veterinary diagnostic product lines to cater to this growing demand.

Rising Incidence of Zoonotic and Infectious Diseases in Animals: The increase in zoonotic diseases (diseases that spread from animals to humans) has driven the demand for rapid and accurate diagnostic tools. The World Health Organization (WHO) reports that over 60% of known infectious diseases in humans originate from animals, and 75% of emerging infectious diseases are of animal origin. This emphasizes the need for early detection through advanced veterinary diagnostics. The spread of African Swine Fever (ASF) has led to increased diagnostic testing for pigs in Europe & Asia, pushing governments and private sectors to invest in veterinary diagnostic kits and point-of-care testing solutions.

 

Market Opportunities

Technological Advancements in Veterinary Diagnostics: The introduction of AI-based diagnostic tools, molecular diagnostics, and point-of-care testing (POCT) is revolutionizing veterinary diagnostics. The global veterinary molecular diagnostics market is expected to grow at a CAGR of 8.9% from 2023 - 2030, indicating strong potential for innovation and investment. Companies like Zoetis & Heska Corporation are investing in AI-driven digital imaging solutions, allowing veterinarians to quickly detect abnormalities in animal scans, leading to faster treatment decisions.

Expanding Veterinary Healthcare Infrastructure in Emerging Markets: Developing countries like India, Brazil & China are witnessing significant investments in veterinary hospitals and clinics, driving the demand for advanced diagnostics. The Indian veterinary healthcare market is projected to grow at 10-12% annually, driven by increased government funding and private investments. In China, the government has strengthened regulations for animal disease control, leading to increased adoption of diagnostic kits for livestock diseases like Foot-and-Mouth Disease (FMD). This has created opportunities for companies offering rapid and accurate veterinary diagnostics.

 

Market Challenges

High Cost of Veterinary Diagnostic Tests: Advanced diagnostic procedures like MRI, CT scans & genetic testing are expensive, limiting their accessibility in cost-sensitive regions. For example, a single MRI scan for a pet in the U.S. can cost between $1,500 and $3,000, making it unaffordable for many pet owners without insurance. Many small veterinary clinics in rural areas hesitate to adopt expensive diagnostic technologies due to budget constraints, limiting market penetration for high-end diagnostic solutions.

Lack of Awareness and Skilled Professionals in Developing Regions: In many low-income countries, veterinary diagnostics are underutilized due to a lack of awareness among pet & livestock owners and a shortage of skilled veterinary professionals. The World Organization for Animal Health (WOAH) estimates that only 38% of low-income countries have adequate veterinary infrastructure. In Africa, many livestock farmers lack access to proper veterinary diagnostic services, leading to the spread of diseases like Bovine Tuberculosis and Brucellosis due to undetected infections.

 

Veterinary Diagnostics Market Segmentation:

By Product Type

• Clinical Biochemistry

• Hematology

• Molecular Diagnostics

• Immunodiagnostics

• Diagnostic Imaging

• Urinalysis

• Microbiology Testing

 

By Animal Type

• Companion Animals (Dogs, Cats, Horses, Others)

• Livestock Animals (Cattle, Swine, Poultry, Sheep & Goats, Others)

 

By Technology

• ELISA

• PCR (Polymerase Chain Reaction)

• Lateral Flow Assay

• Immunohistochemistry

• Mass Spectrometry

• Biosensors

 

By End User

• Veterinary Hospitals & Clinics

• Reference Laboratories

• Point-of-Care Testing Centers

• Research Institutes & Universities

 

By Region

• North America

• Europe

• Asia-Pacific

• Latin America

• Middle East & Africa

 

Veterinary Diagnostics Market Segment Analysis

By Product Type:

Leading Segment: Clinical Biochemistry

Clinical biochemistry holds the largest market share in the veterinary diagnostics market, accounting for a substantial portion of the total market. This segment involves tests for the analysis of blood chemistry, liver function, kidney function & electrolyte balance in animals. The demand for clinical biochemistry tests is driven by the need for routine health checks and disease diagnosis in both companion and livestock animals. The increasing prevalence of chronic diseases like diabetes & kidney failure in pets, as well as livestock diseases, boosts the demand for clinical biochemistry diagnostics. In 2023, clinical biochemistry made up over 25% of the global veterinary diagnostics market.

Fastest-Growing Segment: Molecular Diagnostics

Molecular diagnostics is the fastest-growing segment in the veterinary diagnostics market, growing at a CAGR of 12.5%. This segment is experiencing rapid growth due to the increasing demand for more accurate, early-stage detection of diseases in animals. Molecular diagnostics, including PCR (Polymerase Chain Reaction) technology, is increasingly used for detecting infectious diseases, genetic disorders & identifying pathogens in both companion & livestock animals. The adoption of PCR testing for zoonotic diseases, as well as advancements in genomics and molecular biology, is significantly contributing to the expansion of this segment.

 

By Animal Type:

Leading Segment: Companion Animals (Dogs, Cats, Horses, Others)

Companion animals, particularly dogs & cats, represent the largest segment in the veterinary diagnostics market. This segment holds a significant share of over 60% of the total market, driven by the growing pet adoption trend, increasing expenditure on pet care & rising awareness of pet health. Veterinary diagnostics for companion animals are essential for managing diseases, routine check-ups, and preventative care. The demand for diagnostics in this segment is particularly strong in developed markets, where owners invest in advanced diagnostic testing to ensure the health of their pets.

Fastest-Growing Segment: Livestock Animals (Cattle, Swine, Poultry, Sheep & Goats, Others)

The fastest-growing segment is livestock animals, projected to grow at a CAGR of 9.2%. This growth is primarily driven by the need for enhanced disease control, monitoring & management in the agricultural sector. The increasing demand for meat & dairy products, along with growing concerns regarding zoonotic diseases & livestock health, are contributing to this growth. Diagnostic tests in this segment help ensure animal health, improve productivity & prevent outbreaks of diseases like avian influenza and foot-and-mouth disease.

 

By Technology:

Leading Segment: ELISA (Enzyme-Linked Immunosorbent Assay)

ELISA technology holds the largest market share in the veterinary diagnostics market, accounting for approximately 30% of the market. ELISA is commonly used for detecting antibodies and antigens in animal blood samples, particularly for diseases such as feline leukemia, canine parvovirus, and various livestock diseases. The widespread use of ELISA due to its reliability, affordability, and ability to test multiple samples at once contributes to its dominant position in the market.

Fastest-Growing Segment: Mass Spectrometry

Mass spectrometry is the fastest-growing technology segment, with a projected CAGR of 14%. This growth is attributed to the increasing need for precise & comprehensive analysis of biological samples, including the identification of pathogens, toxins & metabolites in animals. Mass spectrometry provides high sensitivity & specificity, which is vital for detecting complex diseases & improving diagnostic accuracy, especially in companion animals & livestock with emerging health concerns.

 

By End-User:

Leading Segment: Veterinary Hospitals & Clinics

Veterinary hospitals and clinics dominate the veterinary diagnostics market, holding the largest share due to the increasing number of pet owners seeking professional medical care for their animals. These facilities offer a wide range of diagnostic services, from routine check-ups to complex diagnostic tests for diseases. The growing number of veterinary clinics & hospitals globally, along with the increasing focus on specialized care & treatments, contributes to the sustained demand in this segment.

Fastest-Growing Segment: Point-of-Care Testing Centers

Point-of-care testing centers are the fastest-growing segment, projected to grow at a CAGR of 10.8%. These centers provide on-site diagnostics & allow for rapid results, which are essential for both companion animals and livestock, particularly in remote areas or during emergencies. With the increasing need for faster diagnoses & the convenience of having results available immediately, this segment is experiencing rapid adoption, especially in rural areas and for urgent veterinary care.

 

By Region:

Leading Region: North America

North America holds the largest share of the veterinary diagnostics market, accounting for more than 40% of the global market. The region is supported by a high number of pet owners, a well-established veterinary healthcare infrastructure & significant investments in research and development. The U.S., in particular, leads the market due to high levels of pet adoption, increasing healthcare expenditure on animals & a well-developed network of veterinary hospitals and diagnostic laboratories. Additionally, the rising awareness of zoonotic diseases & advancements in diagnostic technologies further bolster the market.

Fastest-Growing Region: Asia-Pacific

The Asia-Pacific (APAC) region is the fastest-growing region for the veterinary diagnostics market, with a projected CAGR of 9.5%. This growth is driven by the increasing pet ownership in countries like China, India, and Japan, as well as rising livestock health concerns. The growing demand for advanced veterinary care in emerging economies, increased government support for animal health initiatives & expanding veterinary healthcare infrastructure are the key factors propelling the market in this region. Additionally, the rise in disposable income & changing attitudes towards animal welfare in countries like China and India are contributing to this regional growth.

 

Veterinary Diagnostics Market Key Players:

• IDEXX Laboratories, Inc.

• Thermo Fisher Scientific Inc.

• Zoetis Inc.

• Heska Corporation

• Neogen Corporation

• bioMérieux SA

• IDvet

• Virbac

• Randox Laboratories Ltd.

• Bio-Rad Laboratories

 

Veterinary Diagnostics Market Report Coverage

Report Attribute	Details
Forecast Period	2024 – 2032
Market Size Value in 2023	USD 8.5 Billion
Revenue Forecast in 2032	USD 18 Billion
Overall Growth Rate	CAGR of 9.1% (2024 – 2032)
Base Year for Estimation	2023
Historical Data	2017 – 2021
Unit	USD Million, CAGR (2024 – 2032)
Segmentation	By Product Type, By Animal Type, By Technology, By End User, By Geography
By Product Type	Clinical Biochemistry; Hematology; Molecular Diagnostics; Immunodiagnostics; Diagnostic Imaging; Urinalysis; Microbiology Testing
By Animal Type	Companion Animals (Dogs, Cats, Horses, Others); Livestock Animals (Cattle, Swine, Poultry, Sheep & Goats, Others)
By Technology	ELISA; PCR (Polymerase Chain Reaction); Lateral Flow Assay; Immunohistochemistry; Mass Spectrometry; Biosensors
By End User	Veterinary Hospitals & Clinics; Reference Laboratories; Point-of-Care Testing Centers; Research Institutes & Universities
By Region	North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country Scope	US, Canada, Germany, China, India, etc.
Market Drivers	Increasing pet ownership, rising prevalence of zoonotic diseases, advancements in veterinary diagnostic technologies
Pricing and Purchase Options	Customized options available

 

Veterinary Diagnostics Market Recent Developments:

• In January 2024, Zoetis Inc. enhanced its versatile diagnostic platform, Vetscan Imagyst, by launching AI-driven urine sediment analysis. This improvement seeks to offer veterinarians enhanced accuracy & efficiency in their diagnostic processes.

• In March 2022, Companion Animal Health entered into a strategic partnership with HT BioImaging to co-brand and exclusively distribute the HTVet product throughout the United States and Canada. This collaboration is designed to advance diagnostic imaging solutions for veterinary practices.

• In August 2022, PepiPets introduced a mobile diagnostic testing service that enables clients to have at-home diagnostic testing for their pets. This service is designed to improve convenience & minimize stress for both pets & their owners by removing the necessity of clinic visits.

 

Veterinary Diagnostics Market Future Outlook

The Veterinary Diagnostics Market is poised for significant growth, driven by advancements in diagnostic technologies, increasing prevalence of zoonotic diseases & rising pet ownership globally. The demand for point-of-care (POC) testing, molecular diagnostics & AI-driven diagnostic tools is expected to surge as veterinarians seek faster, more accurate, and cost-effective solutions. Companies are investing heavily in PCR-based diagnostics, next-generation sequencing (NGS), and biomarker-based tests to detect diseases in livestock and companion animals at earlier stages. Government initiatives focusing on animal disease control programs, particularly in bovine tuberculosis (bTB), brucellosis, and avian influenza, will further propel market expansion. Additionally, the integration of cloud-based veterinary diagnostic solutions and telemedicine is transforming how veterinarians access and interpret diagnostic data in real-time. Despite regulatory hurdles and high costs associated with advanced diagnostic tests, increasing investment in portable veterinary diagnostic devices and the expansion of diagnostic laboratories in emerging markets are expected to fuel sustained market growth. By 2030, the veterinary diagnostics market is anticipated to witness strong growth, with Asia-Pacific & Latin America emerging as key regions due to expanding livestock production and improving veterinary healthcare infrastructure.